Egypt to receive 25 million doses of Russia's Sputnik V coronavirus vaccine
Russia will supply Egypt with 25 million doses of its Sputnik V coronavirus vaccine, amid continued human trials on the immunisation treatment.Russia’s RDIF sovereign wealth fund announced the deal on Wednesday, saying it had agreed to supply Egypt with the vaccine via Pharco, which it described as one of the country’s leading pharmaceutical groups.“The agreement between RDIF and Pharco will help Egypt obtain an efficient and safe vaccine, Sputnik V, for almost 25% of its population,” RDIF chief executive Kirill Dmitriev said in a statement.Russia raised concerns among Western scientists by ap...
COVID-19 vaccine to be priced fairly, ministry says
By MO JINGXI | CHINA DAILY | Updated: 2020-10-01 08:21Foreign Ministry spokesman Wang Wenbin on Wednesday dismissed media reports that China's coronavirus vaccine products are being priced much higher than those produced by Western countries, saying that the reports are groundless.Speaking at a news conference in Beijing, Wang said that as the vaccines are still being developed in different countries, how they will be priced is still unknown."But for the Chinese side, one thing is clear. That is, we will make the COVID-19 vaccine a global public good sold to the world at a fair and reasonable ...
Moderna's Covid-19 vaccine won't be ready by US election: report
Washington (AFP) - US biotech firm Moderna won't seek an emergency use authorization for its coronavirus vaccine before November 25, its CEO told the Financial Times on Wednesday.The news deals a blow to President Donald Trump's hopes of having an injection ready before the election to give his campaign a much-needed boost.Stephane Bancel told the newspaper: "November 25 is the time we will have enough safety data to be able to put into an EUA file that we would send to the FDA (Food and Drug Administration) — assuming that the safety data is good, i.e. a vaccine is deemed to be safe."Trump, w...
Sharjah airport frontliners receive COVID-19 vaccine
Abu Dhabi: Frontline staff at the Sharjah International Airport have started receiving their first doses of the COVID-19 vaccine, the UAE Ministry of Health and Prevention announced on Tuesday.The vaccine is being delivered in cooperation with the Sharjah Government, and is in line with national efforts to protect frontline workers from COVID-19. The vaccine was granted emergency approval last month for use by frontliners, including those working in aviation.“The move comes as part of MoHAP’s efforts in cooperation with competent authorities to safeguard the health and safety of the frontline ...
Ihekweazu: we can’t produce vaccine
Nigeria Centre for Disease Control (NCDC) Director-General Dr. Chikwe Ihekweazu on Monday declared that Nigeria does not have enough capacity for production of vaccines.Ihekweazu, who made this known during a television programme in Abuja, expressed optimism that the country will not lack access to vaccines when they are available.He, however, said most of the vaccines would have to be produced in India and other countries, but the country will leverage on its sophisticated distribution system through the National Primary Health Care Development Agency (NPHCDA).
Time to prepare for tourism reopening
One of the sectors that will lead the Philippine recovery once a vaccine becomes available to the public is tourism because of its direct linkage to economic development.Every rich nation on the planet has a vibrant tourism industry, made possible by robust infrastructure and transport network, and the wide availability of amenities such as convention centers, hotels, resorts, restaurants and shopping centers.Following months of lockdown, many residents of Metro Manila are apparently yearning for travel, as evident in the large crowd that swelled along Roxas Boulevard to witness the “white san...
US company hopeful of UK trials for COVID-19 vaccine
LONDON: An experiment has been proposed to take place in the UK that will see volunteers infected with a weakened form of COVID-19 in the hope that it could act as an effective vaccine.The trial, the brainchild of US biotech company Codagenix, may receive permission to begin before the end of the year.The theory behind the vaccine using an “attenuated” virus, engineered in a laboratory, stems from how COVID-19 uses pieces of genetic code, called codons, normally used by human cells to identify amino acids in order to build proteins, to trick the cells into helping the virus replicate inside a ...
Uzbekistan to create its own COVID-19 vaccine
By TrendScientists from Uzbekistan are working to create the country’s own vaccine against coronavirus, Trend reports with reference to the Ministry of Health in Uzbekistan.According to the ministry, scientists are working in collaboration with the country’s pharmaceutical companies.The development of local vaccine will help the country not to depend on imports.The ministry further said the domestically made vaccine may be exported to other countries.Earlier, Chief Sanitary Inspector in Uzbekistan Nurmat Otabekov said that the country is not working on creation of a vaccine. He emphasized that...
COVID-19 mutations no problem for vaccine candidates, experts say
By Zhang Zhihao | China Daily | Updated: 2020-09-26 07:32The genome of the novel coronavirus is generally stable across the globe and current mutations of the virus will not affect the potency or development of vaccine candidates, Chinese experts said on Friday.According to the journal Nature, there are nine COVID-19 vaccine candidates in phase three clinical trials around the world, with four of the vaccines from China. Yang Sheng, deputy director of the bureau of drug registration at the National Medical Products Administration, said that all four Chinese vaccines are conducting their trials...
Approved COVID-19 vaccine by April 2021? FDA says that’s ‘possible’
Approved COVID-19 vaccine by April 2021? FDA says that’s ‘possible’(Philstar.com) – September 25, 2020 – 1:10pmMANILA, Philippines — A vaccine against the coronavirus disease may be approved by April 2021, the best case scenario, the country’s Food and Drug Administration said Friday.“The best case scenario, if clinical trials are completed by December or January and a company would file with FDA an application then that’s possible by April 2021 that we will have an approved vaccine,” FDA Director-General Eric Domingo said in a forum.“Best case scenario ‘yun. ‘Yung three to six months (clinica...